Quest Diagnostics (DGX) Operating Leases (2019 - 2025)
Quest Diagnostics (DGX) has disclosed Operating Leases for 7 consecutive years, with $711.0 million as the latest value for Q4 2025.
- Quarterly Operating Leases fell 1.93% to $711.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $711.0 million through Dec 2025, down 1.93% year-over-year, with the annual reading at $711.0 million for FY2025, 1.93% down from the prior year.
- Operating Leases hit $711.0 million in Q4 2025 for Quest Diagnostics, up from $534.0 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $725.0 million in Q4 2024 to a low of $489.0 million in Q1 2024.
- Historically, Operating Leases has averaged $546.8 million across 5 years, with a median of $507.5 million in 2023.
- Biggest five-year swings in Operating Leases: fell 22.73% in 2023 and later skyrocketed 44.14% in 2024.
- Year by year, Operating Leases stood at $679.0 million in 2021, then dropped by 4.12% to $651.0 million in 2022, then decreased by 22.73% to $503.0 million in 2023, then soared by 44.14% to $725.0 million in 2024, then dropped by 1.93% to $711.0 million in 2025.
- Business Quant data shows Operating Leases for DGX at $711.0 million in Q4 2025, $534.0 million in Q3 2025, and $540.0 million in Q2 2025.